Zenas BioPharma, Inc.
ZBIO
$6.94
-$0.81-10.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -52.60M | -38.61M | -37.98M | -27.80M | -24.59M |
| Total Depreciation and Amortization | 33.00K | 36.00K | 35.00K | 33.00K | 30.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.15M | 2.97M | 1.83M | 1.80M | 1.59M |
| Change in Net Operating Assets | 8.87M | 4.54M | 5.16M | 6.87M | 7.57M |
| Cash from Operations | -38.55M | -31.06M | -30.96M | -19.10M | -15.40M |
| Capital Expenditure | -74.00K | 0.00 | -35.00K | -22.00K | -17.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.66M | -26.76M | -- | -- | -- |
| Cash from Investing | -3.74M | -26.76M | -35.00K | -22.00K | -17.00K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.33M | 234.42M | 124.00K | 42.00K | 50.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 178.38M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.47M | -439.00K | -766.00K | -656.00K | -- |
| Cash from Financing | 1.85M | 233.98M | 177.74M | -614.00K | 50.00K |
| Foreign Exchange rate Adjustments | 141.00K | -52.00K | 32.00K | 36.00K | -87.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.30M | 176.11M | 146.78M | -19.70M | -15.45M |
